News

Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and ...
Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug ...